These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9339867)

  • 21. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy.
    Jović NJ; Mirković D; Majkić-Singh N; Milovanović DD
    Adv Exp Med Biol; 1999; 467():297-302. PubMed ID: 10721069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
    Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A
    Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability.
    Buchanan N
    Seizure; 1995 Sep; 4(3):233-6. PubMed ID: 7582659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lamotrigine as add-on therapy in adult patients with refractory epilepsy.
    Yen DJ; Yiu CH; Kwan SY; Lin YY; Su MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 May; 59(5):303-7. PubMed ID: 9248123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine and valproate: efficacy of co-administration in a pediatric population.
    Thomé-Souza S; Freitas A; Fiore LA; Valente KD
    Pediatr Neurol; 2003 May; 28(5):360-4. PubMed ID: 12878297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of lamotrigine on patients with refractory epilepsy: the Leicester experience.
    Martin PJ; Millac PA
    Seizure; 1994 Sep; 3(3):209-13. PubMed ID: 8000715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lamotrigine as an add-on drug in typical absence seizures.
    Ferrie CD; Robinson RO; Knott C; Panayiotopoulos CP
    Acta Neurol Scand; 1995 Mar; 91(3):200-2. PubMed ID: 7793236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
    Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
    Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamotrigine: clinical experience in 93 patients with epilepsy.
    Buchanan N
    Acta Neurol Scand; 1995 Jul; 92(1):28-32. PubMed ID: 7572057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy.
    Cerminara C; Montanaro ML; Curatolo P; Seri S
    Neurology; 2004 Jul; 63(2):373-5. PubMed ID: 15277643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lamotrigine add-on therapy for childhood-onset refractory epilepsy: comparison of the efficacy between 3 months and 6 months after initiation].
    Watanabe K; Kobayashi K; Endoh F; Yoshinaga H; Ohtsuka Y
    No To Hattatsu; 2011 Nov; 43(6):453-8. PubMed ID: 22180960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to replace lamotrigine with valproate.
    Steinhoff BJ
    Epilepsia; 2006 Nov; 47(11):1943-4. PubMed ID: 17116036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children].
    Huang TS; Zhu JL; Li B; Hu Y; Chen L; Liao JX
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):653-5. PubMed ID: 19695193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).
    Donaldson JA; Glauser TA; Olberding LS
    Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamotrigine therapy of epilepsy with Angelman's syndrome.
    Dion MH; Novotny EJ; Carmant L; Cossette P; Nguyen DK
    Epilepsia; 2007 Mar; 48(3):593-6. PubMed ID: 17326790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vulnerability of an epileptic case to psychosis: sodium valproate with lamotrigine, forced normalization, postictal psychosis or all?
    Turan AB; Seferoglu M; Taskapilioglu O; Bora I
    Neurol Sci; 2012 Oct; 33(5):1161-3. PubMed ID: 22131039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.